TrialEye (London, England)2017

Second-year visual acuity outcomes of nAMD patients treated with aflibercept: data analysis from the UK Aflibercept Users Group.

H Almuhtaseb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.